3rd Supply Chain and Logistics for Cell Therapies Summit

Memo

The demand for cell therapy is increasing and with a growing number of companies creating therapeutics, there has never been a more important time to optimize your supply chain to create a dependable supply of cell therapy treatment. In the wake of Covid, strategies to mitigate risk in supply chain and patient operations can now be shared to plan for hindrances in the future. Here's what you can expect from our 2022 event:With exclusive presentations and discussions on key industry challenges, gain valuable insights from leaders in the field including GlaxoSmithKline, Legend Biotech, Iovance, Gamida Cell, and more.Discuss standardization, review digital system implementation, prepare for upscaling and optimize cryopreservation in person with like-minded supply chain professionals all to maximize efficiency and create a patient-centric end-to-end system.Download the full event guide to learn more about our speakers, agenda topics, and in-person networking opportunities.URLs:Tickets: https://go.evvnt.com/984297-2?pid=5569Brochure: https://go.evvnt.com/984297-4?pid=5569Prices:Early Bird 1 - FULL ACCESS PASS: Conference + Workshop Day - Service/Solution Provider Pricing (Save $1650): USD 4196.0,Early Bird 1 - Conference Only - Service/Solution Provider Pricing (Save $900): USD 2699.0,Early Bird 1 - FULL ACCESS PASS: Conference + Workshop Day - Drug Developer Pricing (Save $1650): USD 3296.0,Early Bird 1 - Conference Only - Drug Developer Pricing (Save $900): USD 2099.0,Early Bird 1 - FULL ACCESS PASS: Conference + Workshop Day - Academic Pricing (Save $1650): USD 2596.0,Early Bird 1 - Conference Only - Academic Pricing (Save $900): USD 1699.0,On the Door- FULL ACCESS PASS: Conference + Workshop Day - Service/Solution Pricing: USD 5846.0,On the Door - Service/Solution Provider Pricing: USD 3599.0,On the Door: Conference + Workshop Day - Drug Developer Pricing: USD 4946.0,On the Door - Drug Developer Pricing: USD 2999.0Speakers: William Shingler Senior Director, Patient and Cell Management Autolus Ltd, Alicia Dixon Senior Director, Cell Therapy Operations and Patient Services Gamida Cell, Chia-Hsing Pi Scientist II, Process Development BlueRock Therapeutics, David Townson VP Immuno-Oncology and Precision Medicine, Bayer Oncology Bayer, Christopher Baldwin Senior Director, Cell and Gene Therapy Supply Chain GlaxoSmithKline, Kara Zubey Senior Director Cell Therapy Commercialization GlaxoSmithKline, Sarah Miller Principal Supply Chain Planner, Individualized Therapies Genentech, Susie Ro Associate Director, CGT Logistics GlaxoSmithKline, Karen Moniz Technical Director ICCBBA, Michael Mehler Director, Global Site Operations Immatics, Sheng Lin-Gibson Chief NIST Biosystems and Biomaterials Division, Steve Macrides Senior Vice President, Supply Chain and Logistics Iovance, Albert Ribickas Manager BMT Laboratory Moffitt Cancer Center, Hang Yuan Vice President, Process Development BlueRock Therapeutics, Kawa Chiu Vice President of CMC, Supply Chain and eSystems Lyell Immunopharma, Tiffany Clement Cell Therapies Core Inventory Management and Moffitt Cancer Center, Guanglin Yu Research Assistant University of Minnesota, Katie Hansen Program Specialist Seattle Children's, Kevin Liao Senior Manager, Supply Chain Vor Biopharma, Stephen Chen Chief Operating Officer / Chief Technical Officer NKGen Biotech, Daniel Lasry Senior Manager, Supply Chain Vericel Corporation, David Setboun Chief Operating Officer Brainstorm Cell Therapeutics, Laura Deschenes Vice President, Head of Supply Chain and CMC Portfolio Sana Biotechnology, Vishal Khanderia Senior Director, Supply Chain Beam Therapeutics Date and Time: On Monday April 25, 2022 at 8:00 am (ends Wednesday April 27, 2022 at 3:30 pm) Venue Details: Crowne Plaza Boston - Woburn, an IHG Hotel, 15 Middlesex Canal Park Rd, Woburn, Massachusetts, 01801, United States